Display options
Share it on

Res Pharm Sci. 2016 Mar-Apr;11(2):145-51.

The effects of Anethum graveolens essence on scopolamine-induced memory impairment in mice.

Research in pharmaceutical sciences

Azadeh Mesripour, Mahmoud Rafieian-Kopaei, Bahareh Bahrami

Affiliations

  1. Department of Pharmacology and Toxicology and Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
  2. Medical Plants Research Center, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, I.R. Iran.

PMID: 27168754 PMCID: PMC4852659

Abstract

Since Anethum graveolens (Dill) has phytoestrogenic compounds and it is proven that estrogens exert beneficial effects on cognition; the aim of this study was to understand if this plant can improve memory performance. Male Balb/c mice weighing 25-30 g were used in this study and memory was assessed by the novel object recognition task. In this method, the difference in the exploration time between a familiar object and a novel object is taken as an index of memory performance (recognition index, RI). Scopolamine significantly reduced memory index (RI = -15.5% ± 3.0). Dill essence (100 mg/kg, ip) prevented the harmful effects of scopolamine on memory (RI = 40% ± 5.5), thus RI did not differ with control animals (RI = 50% ± 5.8). In addition, 17-β estradiol also prevented memory impairment in animals (0.2 mg/kg, ip; RI = 35.8% ± 6.5). Nevertheless, the beneficial effects of dill essence were antagonized by prior injection of tamoxifen (1 mg/kg, ip; RI = -30% ± 7.8). Although phytoesrogens are not steroids, the beneficial effect of dill on memory, at least in part, may have been achieved by estrogenic receptors present in the brain. Thus dill essence could be promising in improving memory and cognition, mainly in postmenopausal women.

Keywords: Anethum graveolens; Dill; Estrogen; Memory; Phytoestrogen; Tamoxifen

References

  1. Behav Brain Res. 1988 Nov 1;31(1):47-59 - PubMed
  2. Lancet. 2000 Aug 26;356(9231):708-12 - PubMed
  3. Neuroscience. 1994 Jun;60(4):843-55 - PubMed
  4. Neuroimage. 2004 Jan;21(1):364-71 - PubMed
  5. J Comp Neurol. 2001 Jul 16;436(1):64-81 - PubMed
  6. Basic Clin Pharmacol Toxicol. 2008 Apr;102(4):377-81 - PubMed
  7. Planta Med. 2003 Jul;69(7):589-99 - PubMed
  8. Trends Pharmacol Sci. 2002 Nov;23(11):527-34 - PubMed
  9. Behav Neurosci. 2001 Apr;115(2):384-93 - PubMed
  10. J Neurosci. 1992 Jul;12(7):2549-54 - PubMed
  11. J Reprod Infertil. 2015 Jan-Mar;16(1):10-7 - PubMed
  12. Endocrinology. 2003 May;144(5):2055-67 - PubMed
  13. J Am Geriatr Soc. 2002 Apr;50(4):707-12 - PubMed
  14. J Pharmacol Toxicol Methods. 2006 Sep-Oct;54(2):99-105 - PubMed
  15. Neurobiol Learn Mem. 2005 Sep;84(2):132-7 - PubMed
  16. Endocrinology. 1997 Mar;138(3):863-70 - PubMed
  17. Neuroreport. 1997 Mar 24;8(5):1173-8 - PubMed
  18. Horm Behav. 1998 Oct;34(2):149-62 - PubMed
  19. J Comp Neurol. 1997 Dec 1;388(4):603-12 - PubMed
  20. Brain Res Rev. 2008 Mar;57(2):309-20 - PubMed
  21. Semin Reprod Med. 2004 Feb;22(1):11-23 - PubMed
  22. Curr Neurol Neurosci Rep. 2010 Sep;10(5):359-66 - PubMed

Publication Types